Clinical Trial Update: Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating an oxytocin-deficient state and its clinical relevance in pituitary/hypothalamic disorders; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Diabetes Insipidus
• Hypopituitarism
• Hypothalamic Disease
• Panhypopituitarism
• Pituitary Disease

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Hypopituitarism, Central Diabetes Insipidus | Phase 4 | Status: COMPLETED